Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
I-MED Pharma is collaborating with KMG International Limited to manufacture and supply PPE and COVID-19 diagnostic tests.
read more
Wednesday, April 01, 2020
I-Mab announced a strategic partnership with Kalbe Genexine Biologics.
read more
Monday, December 17, 2018
I-Mab Biopharma and CSPC Pharmaceutical jointly announced a strategic partnership between the two companies.
read more
I-Mab announced the appointment of Fernando J. Salle´s, Ph.D., CLP®, as Senior Vice President, Head of U.S. & EU Business Development, effective March 30, 2020.
read more
I-Mab Biopharma and ABL Bio, jointly announced that two companies had entered into a partnering agreement for ABL Bio to in-license the global rights excluding Greater China to I-Mab's bispecific antibodies of undisclosed target with licensing ...
read more
Wednesday, September 26, 2018
WuXi Biologics and I-Mab Biopharma jointly announced that I-Mab has expanded strategic collaboration with WuXi Biologics and licensed proprietary WuXiBody Platform to develop three bispecific antibodies.
read more
Advarra has been selected by the I-ACT for Children to provide central institutional review board services to the organization’s pediatric clinical trial site network.
read more
I Peace, Inc. announced that the company has tripled its capacity to manufacture GMP grade iPS cells and iPSC-derived differentiated cells by expanding its facility. The facility's expansion, designed to conform to GMP standard, is now almost ...
read more
Thursday, December 17, 2020
I Peace has obtained approval from an independent IRB for the process of generating iPSCs.
read more
Thursday, January 02, 2025
GMP cell CDMO I Peace, Inc., specializing in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therapies, announced that the number of GMP-grade iPS cells manufactured has reached 100 lines.
read more
Thursday, August 29, 2024
Hyundai Bioscience Co., Ltd, currently pursuing Emergency Use Authorization (EUA) for its oral COVID-19 treatment, Xafty®, for mild-to-moderate cases, announced on August 27th that it has submitted an Investigational New Drug (IND) application for ...
read more
HUYABIO has entered into a clinical collaboration agreement with Bristol-Myers Squibb to evaluate the combination of HUYABIO's HBI-8000.
read more
HUYA Bioscience International has announced the appointment of Akira Miyazato, MD, Ph.D. as VP, Head of Clinical Research and Development in Japan.
read more
Thursday, December 03, 2015
HUYA Bioscience International, a company accelerating drug discovery and development of biopharma innovation originating in China, recently opened its first corporate office in Korea.
read more
Wednesday, February 25, 2015
Huntingdon Life Sciences (HLS) and Harlan Laboratories have announced that the two companies will be rebranded to reflect the new integrated management structure that has been put in place and the broader product and service offerings of the combined...
read more